vs

Side-by-side financial comparison of Amarin Corp plc (AMRN) and FLANIGANS ENTERPRISES INC (BDL). Click either name above to swap in a different company.

FLANIGANS ENTERPRISES INC is the larger business by last-quarter revenue ($52.6M vs $45.1M, roughly 1.2× Amarin Corp plc). FLANIGANS ENTERPRISES INC runs the higher net margin — 1.5% vs -23.3%, a 24.8% gap on every dollar of revenue. On growth, Amarin Corp plc posted the faster year-over-year revenue change (7.0% vs 4.6%). Over the past eight quarters, FLANIGANS ENTERPRISES INC's revenue compounded faster (4.6% CAGR vs -18.3%).

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.

Flanigans Enterprises Inc. is a U.S.-based hospitality company focused on the Florida market. It operates a chain of casual dining restaurants under the Flanigan's Seafood Bar and Grill brand, plus retail package liquor stores. Its key customer segments include local residents and regional tourists, offering affordably priced seafood, American comfort food and assorted beverages.

AMRN vs BDL — Head-to-Head

Bigger by revenue
BDL
BDL
1.2× larger
BDL
$52.6M
$45.1M
AMRN
Growing faster (revenue YoY)
AMRN
AMRN
+2.4% gap
AMRN
7.0%
4.6%
BDL
Higher net margin
BDL
BDL
24.8% more per $
BDL
1.5%
-23.3%
AMRN
Faster 2-yr revenue CAGR
BDL
BDL
Annualised
BDL
4.6%
-18.3%
AMRN

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
AMRN
AMRN
BDL
BDL
Revenue
$45.1M
$52.6M
Net Profit
$-10.5M
$805.0K
Gross Margin
Operating Margin
35.5%
3.2%
Net Margin
-23.3%
1.5%
Revenue YoY
7.0%
4.6%
Net Profit YoY
33.0%
1363.6%
EPS (diluted)
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMRN
AMRN
BDL
BDL
Q1 26
$45.1M
Q4 25
$49.2M
$52.6M
Q3 25
$49.7M
$50.0M
Q2 25
$72.7M
$51.9M
Q1 25
$42.0M
$53.4M
Q4 24
$62.3M
$50.0M
Q3 24
$42.3M
$45.4M
Q2 24
$67.5M
$48.8M
Net Profit
AMRN
AMRN
BDL
BDL
Q1 26
$-10.5M
Q4 25
$-1.2M
$805.0K
Q3 25
$-7.7M
$896.0K
Q2 25
$-14.1M
$1.4M
Q1 25
$-15.7M
$2.7M
Q4 24
$-48.6M
$55.0K
Q3 24
$-25.1M
$184.0K
Q2 24
$1.5M
$1.1M
Gross Margin
AMRN
AMRN
BDL
BDL
Q1 26
Q4 25
47.1%
Q3 25
44.7%
Q2 25
69.2%
Q1 25
59.8%
Q4 24
-15.4%
Q3 24
38.5%
Q2 24
63.4%
Operating Margin
AMRN
AMRN
BDL
BDL
Q1 26
35.5%
Q4 25
-12.9%
3.2%
Q3 25
-22.4%
3.3%
Q2 25
-22.0%
5.5%
Q1 25
-39.9%
6.6%
Q4 24
-84.3%
1.5%
Q3 24
-59.5%
0.7%
Q2 24
-0.8%
4.4%
Net Margin
AMRN
AMRN
BDL
BDL
Q1 26
-23.3%
Q4 25
-2.5%
1.5%
Q3 25
-15.6%
1.8%
Q2 25
-19.4%
2.7%
Q1 25
-37.4%
5.0%
Q4 24
-78.0%
0.1%
Q3 24
-59.4%
0.4%
Q2 24
2.3%
2.3%
EPS (diluted)
AMRN
AMRN
BDL
BDL
Q1 26
Q4 25
$0.00
$0.43
Q3 25
$-0.02
$0.48
Q2 25
$-0.03
$0.75
Q1 25
$-0.04
$1.45
Q4 24
$-0.12
$0.03
Q3 24
$-0.06
$0.11
Q2 24
$0.00
$0.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMRN
AMRN
BDL
BDL
Cash + ST InvestmentsLiquidity on hand
$307.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$66.0M
Total Assets
$645.8M
$142.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMRN
AMRN
BDL
BDL
Q1 26
$307.8M
Q4 25
$302.6M
Q3 25
$286.6M
Q2 25
$298.7M
$732.0K
Q1 25
$281.8M
$244.0K
Q4 24
$294.2M
Q3 24
$305.7M
Q2 24
$306.7M
Total Debt
AMRN
AMRN
BDL
BDL
Q1 26
Q4 25
Q3 25
$20.9M
Q2 25
Q1 25
Q4 24
Q3 24
$22.2M
Q2 24
Stockholders' Equity
AMRN
AMRN
BDL
BDL
Q1 26
Q4 25
$459.3M
$66.0M
Q3 25
$458.9M
$65.2M
Q2 25
$464.9M
$64.3M
Q1 25
$473.7M
$64.0M
Q4 24
$486.2M
$61.6M
Q3 24
$531.4M
$61.2M
Q2 24
$551.9M
$61.3M
Total Assets
AMRN
AMRN
BDL
BDL
Q1 26
$645.8M
Q4 25
$670.8M
$142.1M
Q3 25
$659.8M
$140.6M
Q2 25
$670.1M
$140.7M
Q1 25
$655.7M
$143.3M
Q4 24
$685.3M
$146.9M
Q3 24
$750.6M
$142.1M
Q2 24
$799.9M
$143.1M
Debt / Equity
AMRN
AMRN
BDL
BDL
Q1 26
Q4 25
Q3 25
0.32×
Q2 25
Q1 25
Q4 24
Q3 24
0.36×
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMRN
AMRN
BDL
BDL
Operating Cash FlowLast quarter
$4.9M
Free Cash FlowOCF − Capex
$4.5M
FCF MarginFCF / Revenue
8.5%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
6.14×
TTM Free Cash FlowTrailing 4 quarters
$2.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMRN
AMRN
BDL
BDL
Q1 26
Q4 25
$15.3M
$4.9M
Q3 25
$-12.7M
$3.4M
Q2 25
$16.6M
$1.4M
Q1 25
$-12.5M
$-2.0M
Q4 24
$-13.3M
$7.7M
Q3 24
$-2.4M
Q2 24
$-2.7M
$3.1M
Free Cash Flow
AMRN
AMRN
BDL
BDL
Q1 26
Q4 25
$4.5M
Q3 25
$2.4M
Q2 25
$-1.8M
Q1 25
$-3.0M
Q4 24
$7.0M
Q3 24
Q2 24
$2.2M
FCF Margin
AMRN
AMRN
BDL
BDL
Q1 26
Q4 25
8.5%
Q3 25
4.9%
Q2 25
-3.4%
Q1 25
-5.5%
Q4 24
13.9%
Q3 24
Q2 24
4.5%
Capex Intensity
AMRN
AMRN
BDL
BDL
Q1 26
Q4 25
0.9%
Q3 25
1.9%
Q2 25
6.1%
Q1 25
1.8%
Q4 24
1.5%
Q3 24
Q2 24
1.8%
Cash Conversion
AMRN
AMRN
BDL
BDL
Q1 26
Q4 25
6.14×
Q3 25
3.75×
Q2 25
1.02×
Q1 25
-0.73×
Q4 24
140.02×
Q3 24
Q2 24
-1.81×
2.75×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMRN
AMRN

U.S$35.6M79%
Europe$4.9M11%
Rest-of-World (ROW)$2.8M6%
Licensing & Royalties$1.8M4%

BDL
BDL

Restaurant Food Sales$30.9M59%
Package Store Sales$13.3M25%
Restaurant Bar Sales$7.9M15%

Related Comparisons